ITI Pharma And Healthcare Fund - Regular Plan - Growth

NORMAL RISK
Equity
Equity: Sectoral-Pharma
6M returns
-1.96 %
Current NAV
16.41
1M3M6M1Y3Y5YALL
Loading...
Min. SIP
5000
AUM
₹ 229.9 Cr

Return Calculator

Amount per month5,000
Over the past
1Y
3Y
5Y
Return amount NA
Total Investment
60,000

Investment distribution

Sun Pharmaceutical Industries12.0 %
Divi's Laboratories9.0 %
Max Healthcare Institute6.1 %
Apollo Hospitals Enterprise5.4 %
Lupin5.1 %
Cohance Lifesciences4.5 %

Fund Manager

DS
Dhimant Shah
RK
Rohan Korde
TG
Tanay Gabhawala
RB
Rajesh Bhatia

Fund Information

Launched
10 Nov 2021(3 years ago)
Expense ratio2.35%
Exit LoadExit load of 0.50%, if redeemed within 3 months.
Benchmark index
NIFTY Healthcare TRI.100%

Fund Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Copyright ⓒ 2025 Cherry. All rights reserved.
appstoreplaystore